Resistance to the mTOR Inhibitor Temsirolimus Alters Adhesion and Migration Behavior of Renal Cell Carcinoma Cells through an Integrin α5– and Integrin β3–Dependent Mechanism

Najjar, 2012, Novel agents in renal carcinoma: a reality check, Ther Adv Med Oncol, 4, 183, 10.1177/1758834012443725 Cho, 2012, Two phase 2 trials of the novel Akt inhibitor perifosine in patients with advanced renal cell carcinoma after progression on vascular endothelial growth factor-targeted therapy, Cancer, 118, 6055, 10.1002/cncr.27668 Pantuck, 2007, Prognostic relevance of the mTOR pathway in renal cell carcinoma: implications for molecular patient selection for targeted therapy, Cancer, 109, 2257, 10.1002/cncr.22677 Hutson, 2011, Targeted therapies for the treatment of metastatic renal cell carcinoma: clinical evidence, Oncologist, 16, 14, 10.1634/theoncologist.2011-S2-14 Rasmussen, 2011, Looking beyond inhibition of VEGF/mTOR: emerging targets for renal cell carcinoma drug development, Curr Clin Pharmacol, 6, 199, 10.2174/157488411797189389 Harada, 2013, Acquired resistance to temsirolimus in human renal cell carcinoma cells is mediated by the constitutive activation of signal transduction pathways through mTORC2, Br J Cancer, 109, 2389, 10.1038/bjc.2013.602 Juengel, 2012, Acetylation of histone H3 prevents resistance development caused by chronic mTOR inhibition in renal cell carcinoma cells, Cancer Lett, 324, 83, 10.1016/j.canlet.2012.05.003 Tsaur, 2011, The cdk1-cyclin B complex is involved in everolimus triggered resistance in the PC3 prostate cancer cell line, Cancer Lett, 313, 84, 10.1016/j.canlet.2011.08.026 Knowles, 2013, Integrin αvβ3 and fibronectin upregulate Slug in cancer cells to promote clot invasion and metastasis, Cancer Res, 73, 6175, 10.1158/0008-5472.CAN-13-0602 Tsaur, 2012, Resistance to the mTOR-inhibitor RAD001 elevates integrin α2- and β1-triggered motility, migration and invasion of prostate cancer cells, Br J Cancer, 107, 847, 10.1038/bjc.2012.313 van Zijl, 2011, Initial steps of metastasis: cell invasion and endothelial transmigration, Mutat Res, 728, 23, 10.1016/j.mrrev.2011.05.002 Messai, 2010, Cytokeratin 18 expression pattern correlates with renal cell carcinoma progression: relationship with Snail, Int J Oncol, 36, 1145 Yilmaz, 2010, Mechanisms of motility in metastasizing cells, Mol Cancer Res, 8, 629, 10.1158/1541-7786.MCR-10-0139 Isogai, 2001, Plasminogen activator inhibitor-1 promotes angiogenesis by stimulating endothelial cell migration toward fibronectin, Cancer Res, 61, 5587 Jones, 2007, Transient down-regulation of beta1 integrin subtypes on kidney carcinoma cells is induced by mechanical contact with endothelial cell membranes, J Cell Mol Med, 11, 826, 10.1111/j.1582-4934.2007.00071.x Jones, 2007, CXCR4 chemokine receptor engagement modifies integrin dependent adhesion of renal carcinoma cells, Exp Cell Res, 313, 4051, 10.1016/j.yexcr.2007.07.001 Leroy-Dudal, 2005, Transmigration of human ovarian adenocarcinoma cells through endothelial extracellular matrix involves αv integrins and the participation of MMP2, Int J Cancer, 114, 531, 10.1002/ijc.20778 Heino, 2009, Cellular receptors of extracellular matrix molecules, Curr Pharm Des, 15, 1309, 10.2174/138161209787846720 Li, 2012, Down-regulation of β3-integrin inhibits bone metastasis of small cell lung cancer, Mol Biol Rep, 39, 3029, 10.1007/s11033-011-1065-y Liu, 2012, MYC suppresses cancer metastasis by direct transcriptional silencing of αv and β3 integrin subunits, Nat Cell Biol, 14, 567, 10.1038/ncb2491 Lei, 2011, Proteomics identification of ITGB3 as a key regulator in reactive oxygen species-induced migration and invasion of colorectal cancer cells, Mol Cell Proteomics, 10, 10.1074/mcp.M110.005397 Ahn, 2012, The metastasis gene NEDD9 product acts through integrin β3 and Src to promote mesenchymal motility and inhibit amoeboid motility, J Cell Sci, 125, 1814, 10.1242/jcs.101444 Bauer, 2007, Expression profiling reveals genes associated with transendothelial migration of tumor cells: a functional role for αvβ3 integrin, Int J Cancer, 121, 1910, 10.1002/ijc.22879 Jacquemet, 2013, Role of adhesion receptor trafficking in 3D cell migration, Curr Opin Cell Biol, 25, 627, 10.1016/j.ceb.2013.05.008 Flevaris, 2007, A molecular switch that controls cell spreading and retraction, J Cell Biol, 179, 553, 10.1083/jcb.200703185 Jeruschke, 2013, Protective effects of the mTOR inhibitor everolimus on cytoskeletal injury in human podocytes are mediated by RhoA signaling, PLoS One, 8, e55980, 10.1371/journal.pone.0055980 Goundiam, 2012, Akt and RhoA inhibition promotes anoikis of aggregated B16F10 melanoma cells, Cell Biol Int, 36, 311, 10.1042/CBI20110069